After Chen Jinhe heard Chen Nan's words, he was stunned for a moment.

However, he didn't quite understand what Chen Nan meant.

"standard?"

"What are the quality standards for traditional Chinese medicine pieces?"

"Or...what?"

After Chen Jinhe thought for a long time, he still couldn't think of a reason for setting standards. Setting standards for traditional Chinese medicine pieces is definitely not an easy task, and there are many things involved.

It is definitely not a task that Annan Pharmaceuticals alone can accomplish.

Let alone them, even Xinke Pharmaceutical Company does not have such ability, strength, and rights!

The production of a standard, especially a Chinese medicine standard, involves too many things.

If you create a useless standard and others don't recognize it, what's the point?

Of course, Chen Jinhe, who has been immersed in this art for many years, naturally understands the truth.

What a first-class enterprise does is standard!

"Chen Nan, have you thought about this question? The preparation of Chinese medicine standards is by no means an easy task."

At this time, Chen An smiled slightly: "Dad, you may have misunderstood what Chen Nan meant!"

"The standards for traditional Chinese medicine are indeed beyond what a small company like us can achieve."

"But, have you thought about a question?"

"I am doing chemical research myself, especially the research on the specific active substances of these traditional Chinese medicines."

"This is my professional advantage."

"Secondly, you know what?

Currently, less than 70 types of traditional Chinese medicine have international standards.

The demand for herbal medicines in the United States is also increasing year by year!

The development of new drugs has always been a big problem. Each new drug requires an investment of more than one billion US dollars in scientific research funding.

Therefore, they began to change their perspective and conduct research on active substances of traditional Chinese medicine.

As for the University of California, the main task of our research institute in recent years has been the exploration of active substances in traditional Chinese medicine.

China and the United States have signed a memorandum of cooperation on pharmacopoeia work since 2008. Currently, there are 13 traditional Chinese medicines and 46 standards are included in the US Pharmacopoeia, including salvia miltiorrhiza, Panax notoginseng, Ganoderma lucidum, Schisandra chinensis, honeysuckle, Polygonum multiflorum, cassia twig, coix seed, red ginseng, etc.

33 standards for 9 traditional Chinese medicines were completed by Chinese scientists.

Twenty-four Chinese medicine standards such as Angelica sinensis and Ligusticum chuanxiong have been submitted to the United States Pharmacopeia. Salvia miltiorrhiza, Panax notoginseng, Ganoderma lucidum, Andrographis paniculata, and Centella asiatica are both listed as food supplements (DSC) and herbal medicines (HMC).

The European Pharmacopoeia has also included 66 Chinese medicine standards such as Salvia miltiorrhiza and Panax notoginseng, 4 of which were formulated by Chinese experts, and more than 20 Chinese medicine standards have been submitted to the European Pharmacopoeia and are under review."

"Currently, the person in charge of formulating this standard in China is Professor Guo De'an."

"He was the first Chinese team to formulate the standards for Chinese medicines in the United States Pharmacopoeia and the first Chinese team to formulate the standards for Chinese medicines in the European Pharmacopoeia. He himself is not only the vice chairman of the Herbal Medicine Expert Committee of the United States Pharmacopoeia, but also a member of the European Pharmacopoeia Committee."

“At the University of California, research on active substances in traditional Chinese medicine has always been outsourced.”

“The University of California receives as much as US$190 million in funding for research on active substances in traditional Chinese medicine every year!”

"This is definitely an exaggerated number!"

"My brother's intention is not to simply return to the old business and continue to simply make Chinese patent medicines."

"But we need to get some extracts of traditional Chinese medicine active substances, which are the new standards."

"For example, I won the Chemistry Prize last year because I discovered a new active substance in Panax notoginseng."

"Subsequently, the United States Pharmacopeia included this new substance into the standards of traditional Chinese medicine."

"I believe that since the United States is doing it, the country is also doing it!"

Chen Nan glanced at his brother in surprise, feeling shocked inside!

He didn't expect that after just saying a little, his brother understood what he wanted to do.

At this time, Chen An continued: "Chen Nan, the direction you are thinking of is very good!"

"but……"

"I want to remind you that each traditional Chinese medicine has seven or eight standards, and it is definitely not easy to study and discover the substances in it."

"Our team includes a Nobel Prize winner, seven or eight international chemistry prizes, and American chemistry prizes. In addition, there are a lot of professors and Ph.D.s... all working on research."

"This road may not be feasible!"

"You should know that Mr. Tu Youyou's extraction and discovery of artemisinin was definitely not something that could be accomplished overnight."

Chen Nan smiled: "Brother, I think you may have thought a little wrong!"

"Chinese medicine is the wealth left to us by our ancestors!"

"It is true that the chemical and physical levels of the West are far from what we can currently match, but... our country's research on traditional Chinese medicine, which has been going on for thousands of years, is definitely not what the West can match."

"I just want to ask you something!"

"If we can solve a new substance, or obtain a standard for an important substance in traditional Chinese medicine, do you think we can make money?"

Chen An nodded: "It's undeniable! You can definitely make money."

"As far as I know, China's investment in this field is huge every year."

"A large number of team members, spending countless manpower and material resources, and countless resources are working on it."

"Moreover, Professor Guo De'an also cooperates with us in domestic research institutes. To put it bluntly, this is a kind of outsourcing."

"A type of technology outsourcing."

"Every year, the country spends countless amounts of money in this field. In fact... our country has always wanted to unify international standards and let the Chinese people decide on the standards of traditional Chinese medicine."

"Unfortunately, the difficulty is too high."

"If we can develop a guarantee for traditional Chinese medicine, and it is recognized by the Chinese Pharmacopoeia, the European Pharmacopoeia, and the United States Pharmacopoeia, and if this new substance has significant effects, it will bring tens of millions to 100 million in the United States.

The income ranges from US dollars, which will save the country nearly 300 million yuan."

After Chen Nan heard this number, he was stunned for a moment!

He didn't expect... there were so many?!

A new standard can actually make so much money directly.

The hapaside propionate he just obtained is undoubtedly one of the active substances of Eucommia ulmoides.

And it is an extremely remarkable substance.

The human body's two-way regulating substance is itself a very valuable thing.

The anti-fetal effect of Eucommia ulmoides is based on the two functions of uterine contraction and uterine relaxation based on human hormone levels. If it can be studied and utilized, it will definitely be a good thing for the modern research of Eucommia ulmoides.

If you think about it this way...it seems that 100 million US dollars is not much.

Because this will introduce a new drug for miscarriage, the price of miscarriage drugs will remain high.

Johnson & Johnson in the United States has a new drug priced at 2,000 yuan. This drug brings nearly 2 billion U.S. dollars in revenue to Johnson & Johnson every year.

Chen An continued: "However, there is a problem. Traditional Chinese medicine is a complex system with multiple components, and the single-index component quality control model of chemical drugs is not suitable for traditional Chinese medicine.

So which are the important ingredients and require series of studies is also a question.

Not every active substance in traditional Chinese medicine has research value.

In my opinion, the overall idea of ​​constructing quality control standards for traditional Chinese medicines is to proceed from in-depth research to simple explanations of standards. First, the active ingredients of traditional Chinese medicines are elucidated through a research model combining chemistry and biology.

Secondly, the research is transformed to build overall quality control standards, and finally the established standards are applied to actual control of product quality."

"In addition, there is another problem. Obviously, although many domestic research institutes have appeared in recent years, most of them are not easy to do. The country's outsourcing funds are strictly controlled, and they will never be casual.

Just take it out."

"We can become a subsidiary institution and a listed research institute."

"I do know Professor Guo De'an. After I came back, I visited him once. He hoped that I could join his research institute."

"However, I refuse for the time being."

"Professor Guo appreciates and recognizes me very much. I think... maybe we can cooperate with them."

"If we have results, we can even...become an independent research institute."

At this moment, the family stared at Chen An, a little surprised!

Unexpectedly, he actually had such a friendship with Professor Guo De'an, the head of the international standard setting team.

Chen An saw the whole family staring at him with expectation and surprise, and felt a little embarrassed for a moment.

"Don't look at me like that."

"We have no qualifications, no foundation, and no results. People may not recognize us, and we can't get outsourcing funds."

Chen Nan smiled: "I happen to have a new active substance here. After checking the information, I didn't find any research records. I think... Brother, you can try it."
To be continued...